Nurse Practitioner Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Christina Rodriguez

Nurse Practitioner, Family Richland, WA Nurse Practitioner

NPI 1780285049 CMS profile 10528682

104 Columbia Point Dr, Richland, WA 99352

Open in the dashboard

General payments

$8,943

324 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Christina Rodriguez of Richland, WA is reported in the CMS Open Payments database as having received $8,943 across 324 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Nurse Practitioner, Family profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $242 6
2024 General $3,503 31
2023 General $2,099 97
2022 General $1,701 97
2021 General $1,398 93

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Christina Rodriguez
  • Nurse Practitioner, Family median
  • Middle half of Nurse Practitioner, Family
  • National median

In program year 2025, general payments to Christina Rodriguez were reported at $242. Among 107,232 Nurse Practitioner, Family profiles paid that year, the median was $168 and the middle half received between $53 and $521.

Show as a table
Year Christina Rodriguez Nurse Practitioner, Family median Middle half National median
2019 $0 $39 $18–$91 $163
2020 $0 $32 $17–$76 $114
2021 $1,398 $124 $35–$379 $132
2022 $1,701 $141 $44–$430 $149
2023 $2,099 $154 $49–$476 $160
2024 $3,503 $165 $51–$504 $164
2025 $242 $168 $53–$521 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Genzyme Corporation $2,889 15 payments
  2. Janssen Biotech, Inc. $1,711 78 payments
  3. AbbVie, Inc. $1,595 99 payments
  4. Novartis Pharmaceuticals Corporation $581 57 payments
  5. Incyte Corporation $337 12 payments
  6. Sun Pharmaceutical Industries Inc. $266 11 payments
  7. E.R. Squibb & Sons, L.L.C. $259 4 payments
  8. LEO Pharma Inc. $230 11 payments
  9. Regeneron Healthcare Solutions, Inc. $188 7 payments
  10. Ortho Dermatologics, a division of Bausch Health US, LLC $129 8 payments
  11. Other $758 22 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $5,770 316 payments
  2. Consulting Fee $2,332 1 payment
  3. Education $537 6 payments
  4. Travel and Lodging $304 1 payment
Products named General payments · program years 2021–2025
  1. DUPIXENT $2,843 12 payments
  2. TREMFYA $1,501 62 payments
  3. SKYRIZI $1,090 74 payments
  4. HUMIRA $357 19 payments
  5. OPZELURA $317 11 payments
  6. COSENTYX $314 30 payments
  7. SOTYKTU $259 4 payments
  8. SIMPONI ARIA $239 17 payments
  9. STELARA $239 17 payments
  10. SIMPONI $239 17 payments
  11. Other $2,054 100 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 4 drugs

Part D claims

94

Median for Nurse Practitioner: 389

Drug cost

$1,957

Median for Nurse Practitioner: $21,885

Branded share of claims

0%

Median for Nurse Practitioner: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Clobetasol Propionate Generic 17 $722
Triamcinolone Acetonide Generic 51 $718
Clindamycin Phosphate Generic 13 $309
Nystatin Generic 13 $208

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 229,976 Part D prescribers listed as Nurse Practitioner; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 34 billing codes

Paid by Medicare

$28,931

Medicare's payments for the services billed

Medicare patients

236

Average age 73

Services billed

1,085

117 women, 119 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 68%
Arthritis 42%
Diabetes 24%
Chronic kidney disease 19%
Depression 17%
Cancer 16%
Ischemic heart disease 14%
COPD 14%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 15 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
DUPIXENT
  • GENZYME CORPORATION $2,694
  • Regeneron Healthcare Solutions, Inc. $31
$2,726 — —
TREMFYA
  • Janssen Biotech, Inc. $293
$293 — —
HADLIMA
  • Organon LLC $62
$62 — —
ADBRY
  • LEO Pharma Inc. $54
$54 — —
SKYRIZI
  • AbbVie, Inc. $52
$52 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 15 in the dashboard with a free account

Records

324 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nurse Practitioner, Family in Washington

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record